BRIEF-Heron Therapeutics Announces Preliminary, Unaudited Q4 Results

Reuters
Jan 09
BRIEF-Heron <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Preliminary, Unaudited Q4 Results

Jan 9 (Reuters) - Heron Therapeutics Inc HRTX.O:

  • HERON THERAPEUTICS ANNOUNCES PRELIMINARY, UNAUDITED Q4 AND FULL-YEAR 2025 NET REVENUE; ZYNRELEF® LARGEST CONTRIBUTOR TO Q4 GROWTH

  • HERON THERAPEUTICS INC - REPORTS Q4 2025 NET REVENUE OF $40.5 MILLION

Source text: ID:nGNX1r0qCG

Further company coverage: HRTX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10